| Net Loss | -2.36M |
| Depreciation and amortization | 562K |
| Stock compensation expense | 212K |
| Deferred income taxes | 437K |
| Disposal of assets and other | 22K |
| Allowance for doubtful accounts | -121K |
| Receivables, net | 1.71M |
| Inventories | 1.22M |
| Accounts payable | -1.66M |
| Other current assets and liabilities | -2.07M |
| Net cash provided from (used for) operating activities | |
| Proceeds from stock plans | |
| Repurchase of company stock | |
| Net cash provided from (used for) financing activities | |
| Purchases of short-term investments | -600K |
| Sales of short-term investments | 1.04M |
| Capital expenditures | -72K |
| Net cash provided from (used for) investing activities | |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 64K |
| Net Increase in Cash and Cash Equivalents | -209K |
| Cash and Cash Equivalents, July 1 | 6.79M |
| Cash and Cash Equivalents, September 30 | 6.58M |